SGBI Insider Trading Activity and SEC Form 4 Filings
SGBI insider trading summary
No open-market insider purchases or sales of Sangui Biotech International Inc (SGBI) have been reported on SEC Form 4 in the past 12 months.
Latest SGBI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 13, 2021 | Hubertus Schmelz | Director | Sell | $24K (1,200,000 @ $0.02) |
| Aug 13, 2013 | Lawrence E McCanna | Director | Sell | $77K (3,125 @ $24.78) |
| Feb 26, 2013 | Joachim Fleing | CFO, Secretary | Buy | $4K (11,500 @ $0.33) |
| Jun 8, 2012 | Robert E Smith | Director | Buy | $179K (22,500 @ $7.96) |
| Apr 23, 2012 | Joachim Fleing | CFO, Secretary | Sell | $5K (10,000 @ $0.53) |
| Apr 2, 2012 | Joachim Fleing | CFO, Secretary | Sell | $2K (3,100 @ $0.75) |
| Mar 30, 2012 | Joachim Fleing | CFO, Secretary | Sell | $5K (7,500 @ $0.67) |
| Mar 30, 2012 | Joachim Fleing | CFO, Secretary | Sell | $7K (10,000 @ $0.68) |
| Mar 30, 2012 | Joachim Fleing | CFO, Secretary | Sell | $7K (10,000 @ $0.67) |
| Mar 29, 2012 | Joachim Fleing | CFO, Secretary | Sell | $1K (2,500 @ $0.58) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.